Latest Posts -

Industry Insights

Home Industry Insights
Data Highlights the WATCHMAN FLX Device

Data Highlights the WATCHMAN FLX Device

Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device compared to non-vitamin...

READ MORE
Page 8 of 558
X